advertisement

Accelerate your drug discovery pipeline with AI-powered molecular modelling

BioSim Pro · Trusted by 400+ research institutions globally · 30-day free trial

CRISPR base editing corrects sickle cell mutation in 97% of patient cells · Phase III mRNA cancer vaccine shows 44% reduction in recurrence · Gut microbiome linked to treatment-resistant depression — Nature study · Novo Nordisk acquires rare disease biotech for $3.2B · FDA grants breakthrough designation to novel Alzheimer's antibody ·
CRISPR base editing corrects sickle cell mutation in 97% of patient cells · Phase III mRNA cancer vaccine shows 44% reduction in recurrence · Gut microbiome linked to treatment-resistant depression — Nature study · Novo Nordisk acquires rare disease biotech for $3.2B · FDA grants breakthrough designation to novel Alzheimer's antibody ·

Legal & Privacy Centre · Updated April 2026

Transparency & Your Rights

Biomed Today is committed to being clear, honest and fair about how we operate. This page covers our Privacy Policy, Terms of Use, Accessibility Statement, and Cookie Settings — everything you need to understand your rights and how we handle your information.

Privacy Policy

Effective: April 2026 · Last reviewed: April 2026

Summary: We collect your name, email, and professional details when you subscribe. We use Mailchimp to send newsletters. We do not sell your data. We do not share it with advertisers. We only share professional details with research-focused partner organisations, and you can opt out at any time. We only serve adult professionals aged 18 and over.

1. Who We Are

Biomed Today is an independent biomedical science news publication operating at biomedtoday.com. We are not a registered company at this time. All data and privacy enquiries should be directed to biomedtodaynews@gmail.com. We are committed to protecting your privacy and handling your data in accordance with applicable law including the UK GDPR and EU GDPR.

2. What Information We Collect

3. How We Use Your Information

4. Sponsored Content and Research Submissions

Biomed Today publishes sponsored research and partner content submitted by research institutions, pharmaceutical companies, biotechnology organisations, academic groups, and individual researchers. Content provided to us — including written descriptions, research summaries, graphical abstracts, and images — is published exactly as submitted without editorial modification. We do not independently verify all claims in submitted content. All sponsored and partner content is clearly labelled on our platform.

5. Graphical Abstracts and Scientific Images

Graphical abstracts and scientific illustrations submitted to us are used exclusively to describe and illustrate the associated research on our platform. We do not redistribute these materials, share them with third parties, sell them, or reproduce them in any context beyond their publication on Biomed Today. Submitting researchers and institutions retain full intellectual property rights. Materials may be removed upon written request to biomedtodaynews@gmail.com.

6. Who We Share Your Data With

We do not sell your personal data. We do not share your data with advertisers, advertising agencies, or marketing networks under any circumstances.

7. Adults Only — Age Policy

8. Data Security

9. Data Retention

10. International Data Transfers

11. Your Rights

12. Changes to This Policy

Before you submit, please read the Submission Guidelines in full. All contributors are expected to follow them without exception. To express interest, email us at biomedtodaynews@gmail.com with subject line “Write For Us” and include a brief description of your proposed topic and your professional background.

Data & Privacy Enquiries

For any question about your data, your rights, or this policy, contact us directly. We respond within 30 working days.

Policy Dates